Development and Testing of Cardiovascular Quality Indicators for Rheumatoid Arthritis

Simple item page
atmire.migration.oldid3877
dc.contributor.advisorMarshall, Deborah
dc.contributor.advisorEsdaile, John
dc.contributor.authorBarber, Claire
dc.contributor.committeememberBarnabe, Cheryl
dc.contributor.committeememberFaris, Peter
dc.contributor.committeememberMartin, Liam
dc.date.accessioned2015-12-04T20:28:34Z
dc.date.available2015-12-04T20:28:34Z
dc.date.issued2015-12-04
dc.date.submitted2015en
dc.description.abstractRheumatoid arthritis (RA) is an autoimmune inflammatory arthritis with a 50% increased risk of cardiovascular disease (CVD) related deaths. Traditional CVD risk factors including smoking, hypertension and diabetes may be under-identified and/or undertreated in RA, indicating a gap in care. Quality indicators (QIs) are an important tool for quality improvement and are lacking in this area. The objectives of this dissertation were to: (1) identify existing recommendations pertaining to screening and management of CVD risk in RA; (2) to develop a set of CVD QIs for RA based on the best practices; and (3) to test the QIs in clinical practice. A systematic review of existing CVD QIs and guidelines was conducted (Study 1). All CVD recommendations from high quality guidelines and relevant quality measures were abstracted and best practices in RA were identified. In Study 2, a panel of cardiologists and rheumatologists developed a set of CVD QIs for RA based on best the practices identified. The QIs were presented to an international panel of experts through a novel online modified Delphi process where they were rated and discussed over 3 rounds. In the final study, performance on the CVD QIs was evaluated in 170 early and biologic treated RA patients. Based on the process described above, 11 CVD QIs for RA were developed and were rated as highly relevant and valid by our international panel of experts. This was the first time the online platform was used for QI development and it demonstrated many advantages. Performance on the QIs from our cohort suggests under screening and inconsistent management of CVD risk factors. Also evident, was that our patients had a high burden of obesity, hypertension and smoking, suggesting this is a clinically meaningful gap in care. The primary area for future improvement was noted for QIs relating to communication of CVD risk and coordination of care between rheumatology and primary care. Therefore, future efforts should focus on improving coordination of CVD care as well as improving efficiency of QI measurement and reporting for timely and effective improvements in CVD care.en_US
dc.identifier.citationBarber, C. (2015). Development and Testing of Cardiovascular Quality Indicators for Rheumatoid Arthritis (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/25646en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/25646
dc.identifier.urihttp://hdl.handle.net/11023/2661
dc.language.isoeng
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectEpidemiology
dc.subjectMedicine and Surgery
dc.subject.classificationQuality Indicatorsen_US
dc.subject.classificationRheumatoid arthritisen_US
dc.subject.classificationCardiovascular Diseaseen_US
dc.titleDevelopment and Testing of Cardiovascular Quality Indicators for Rheumatoid Arthritis
dc.typedoctoral thesis
thesis.degree.disciplineCommunity Health Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.item.requestcopytrue
Files
Collections
Open Theses and Dissertations